These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3
41 results:

  • 1. Discovery of wrn inhibitor HRO761 with synthetic lethality in MSI cancers.
    Ferretti S; Hamon J; de Kanter R; Scheufler C; Andraos-Rey R; Barbe S; Bechter E; Blank J; Bordas V; Dammassa E; Decker A; Di Nanni N; Dourdoigne M; Gavioli E; Hattenberger M; Heuser A; Hemmerlin C; Hinrichs J; Kerr G; Laborde L; Jaco I; Núñez EJ; Martus HJ; Quadt C; Reschke M; Romanet V; Schaeffer F; Schoepfer J; Schrapp M; Strang R; Voshol H; Wartmann M; Welly S; Zécri F; Hofmann F; Möbitz H; Cortés-Cros M
    Nature; 2024 May; 629(8011):443-449. PubMed ID: 38658754
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Chemoproteomic discovery of a covalent allosteric inhibitor of wrn helicase.
    Baltgalvis KA; Lamb KN; Symons KT; Wu CC; Hoffman MA; Snead AN; Song X; Glaza T; Kikuchi S; Green JC; Rogness DC; Lam B; Rodriguez-Aguirre ME; Woody DR; Eissler CL; Rodiles S; Negron SM; Bernard SM; Tran E; Pollock J; Tabatabaei A; Contreras V; Williams HN; Pastuszka MK; Sigler JJ; Pettazzoni P; Rudolph MG; Classen M; Brugger D; Claiborne C; Plancher JM; Cuartas I; Seoane J; Burgess LE; Abraham RT; Weinstein DS; Simon GM; Patricelli MP; Kinsella TM
    Nature; 2024 May; 629(8011):435-442. PubMed ID: 38658751
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovering potential wrn inhibitors from natural product database through computational methods.
    Jiang T; Zhang Y; Yu S; Hu B
    J Mol Graph Model; 2024 Jun; 129():108758. PubMed ID: 38507856
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. wrn Is a Promising Synthetic Lethal Target for cancers with Microsatellite Instability (MSI).
    Chan EM; Foster KJ; Bass AJ
    Cancer Treat Res; 2023; 186():313-328. PubMed ID: 37978143
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer.
    Zhang X; Huang Y; Li Q; Zhong Y; Zhang Y; Hu J; Liu R; Luo X
    Front Immunol; 2023; 14():1265911. PubMed ID: 37828981
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and colorectal cancer Patients.
    Côrtes L; Basso TR; Villacis RAR; Souza JDS; Jørgensen MMA; Achatz MI; Rogatto SR
    Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628631
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Germline cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations.
    Liu Y; Gusev A; Kraft P
    Cancer Res; 2023 Apr; 83(8):1191-1202. PubMed ID: 36745477
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Racial/Ethnic and Sex Differences in Somatic cancer Gene Mutations among Patients with Early-Onset colorectal cancer.
    Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
    Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer.
    Hao S; Tong J; Jha A; Risnik D; Lizardo D; Lu X; Goel A; Opresko PL; Yu J; Zhang L
    Proc Natl Acad Sci U S A; 2022 Dec; 119(51):e2211775119. PubMed ID: 36508676
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sensitivities and Dependencies of
    Voutsadakis IA
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295658
    [No Abstract]    [Full Text] [Related]  

  • 11. Provider preferences for anal cancer prevention screening: Results of the International Anal Neoplasia Society survey.
    Plotzker RE; Barnell GM; Wiley DJ; Stier EA; Jay N
    Tumour Virus Res; 2022 Jun; 13():200235. PubMed ID: 35183808
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient colorectal cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy.
    Picco G; Cattaneo CM; van Vliet EJ; Crisafulli G; Rospo G; Consonni S; Vieira SF; Rodríguez IS; Cancelliere C; Banerjee R; Schipper LJ; Oddo D; Dijkstra KK; Cinatl J; Michaelis M; Yang F; Di Nicolantonio F; Sartore-Bianchi A; Siena S; Arena S; Voest EE; Bardelli A; Garnett MJ;
    Cancer Discov; 2021 Aug; 11(8):1923-1937. PubMed ID: 33837064
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The effect of vitamin D on the occurrence and development of colorectal cancer: a systematic review and meta-analysis.
    Xu Y; Qian M; Hong J; Ng DM; Yang T; Xu L; Ye X
    Int J Colorectal Dis; 2021 Jul; 36(7):1329-1344. PubMed ID: 33598751
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Endoscopic submucosal dissection for colorectal lesions: outcomes from a United States experience.
    Gupta N; Rodríguez-Ruiz G; Siddiqui UD; Chapman CG; Donboli K; Hart J; Xiao SY; Waxman I
    Surg Endosc; 2022 Jan; 36(1):236-243. PubMed ID: 33523276
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy.
    Abdelaal MR; Soror SH; Elnagar MR; Haffez H
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477997
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Structure of the helicase core of Werner helicase, a key target in microsatellite instability cancers.
    Newman JA; Gavard AE; Lieb S; Ravichandran MC; Hauer K; Werni P; Geist L; Böttcher J; Engen JR; Rumpel K; Samwer M; Petronczki M; Gileadi O
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33199508
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence of APC and PTEN Alterations in Urachal cancer.
    Nagy N; Reis H; Hadaschik B; Niedworok C; Módos O; Szendrői A; Bíró K; Hager T; Herold T; Ablat J; Black PC; Okon K; Tolkach Y; Csizmarik A; Oláh C; Keresztes D; Bremmer F; Gaisa NT; Kriegsmann J; Kovalszky I; Kiss A; Tímár J; Szász MA; Rink M; Fisch M; Nyirády P; Szarvas T
    Pathol Oncol Res; 2020 Oct; 26(4):2773-2781. PubMed ID: 32754865
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in colorectal cancer.
    Lazzari L; Corti G; Picco G; Isella C; Montone M; Arcella P; Durinikova E; Zanella ER; Novara L; Barbosa F; Cassingena A; Cancelliere C; Medico E; Sartore-Bianchi A; Siena S; Garnett MJ; Bertotti A; Trusolino L; Di Nicolantonio F; Linnebacher M; Bardelli A; Arena S
    Clin Cancer Res; 2019 Oct; 25(20):6243-6259. PubMed ID: 31375513
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells.
    Lieb S; Blaha-Ostermann S; Kamper E; Rippka J; Schwarz C; Ehrenhöfer-Wölfer K; Schlattl A; Wernitznig A; Lipp JJ; Nagasaka K; van der Lelij P; Bader G; Koi M; Goel A; Neumüller RA; Peters JM; Kraut N; Pearson MA; Petronczki M; Wöhrle S
    Elife; 2019 Mar; 8():. PubMed ID: 30910006
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic colorectal cancer.
    Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
    Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.